Koefisien utang jangka dawa marang modal usph.com (USPH)

Simbol lan logo merek US Physical Therapy (USPH)

A shortage of specialized professionals and rising wages are weighing on the profitability of U.S. Physical Therapy (USPH), whose business relies on medical services. This chart illustrates that the asset's market value is 0.80, which complements data on procurement through local partners to optimize costs. The company's environmental development vector is based on the transition to electronic document management and energy saving in physical therapy centers.

USPH US Physical Therapy Inc: Utang jangka dawa marang modal ing interval 04.07.2022 - 30.10.2026
Produk dadi U.S. Physical Therapy

The operational process outsourcing strategy at U.S. Physical Therapy (USPH) enables cost optimization, which is reflected in the financing structure through the current long-term debt-to-equity trend. This ratio compares liabilities with maturities exceeding one year against shareholders' equity, where a decreasing value confirms growing financial autonomy, while an excessive avoidance of borrowing may limit the pace of business scaling.

Analisis perusahaan pesaing

HCA (HCA Holdings) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas Tenet (THC)|FMS (Fresenius Medical) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal SOLV (Solventum Corporation)|encompasshealth.com (EHC) - Kewajiban jangka dawa marang modal|Universal Health Services Corp - Utang jangka dawa marang modal|DVA - Utang jangka dawa marang modal|RDNT (RadNet Corp) - Rasio utang jangka dawa marang ekuitas|OPCH: Rasio silihan jangka dawa marang modal|Utang jangka dawa marang ekuitas Surgery Partners, Inc.|Rasio utang jangka dawa marang ekuitas premierinc.com (PINC)|Utang jangka dawa marang modal EYE|PGNY - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas Ardent Health Partners Inc ARDT|SEM: Rasio utang jangka dawa marang modal|ASTH: Rasio utang jangka dawa marang ekuitas|Pediatrix Medical Group, Inc. - Rasio silihan jangka dawa marang modal|PNTG (The Pennant Group) - Rasio utang jangka dawa marang ekuitas|Organogenesis Holdings Inc. (ORGO) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas NUTX|Auna Corp (AUNA) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas SBC Medical Group (SBC)|Rasio tanggungan utang jangka dawa marang modal evolus.com|Community Health Systems, Inc. - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal The Beauty Health Company (SKIN)|MDWD: Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal BTMD (Biote Corporation)|The Joint Corp. (JYNT) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas DCGO (docgo.com)|PIII (P3 Health Partners, Inc.) - Utang jangka dawa marang modal|GANX: Koefisien utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas EUDA (EUDA Health)|BMGL - Kewajiban jangka dawa marang modal|Utang jangka dawa marang ekuitas CollPlant Biotechnologies Ltd. CLGN|Rasio tanggungan utang jangka dawa marang modal cuprina.com.sg (CUPR)|Concord Medical - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal American Shared Hospital Services Inc AMS|MRM: Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Avalon GloboCare Corp.|DHAI (DIH Holding US, Inc.) - Utang jangka dawa marang modal|Utang jangka dawa marang modal carmellcosmetics.com|Utang jangka dawa marang ekuitas NewGenIvf (NIVF)|Utang jangka dawa marang ekuitas ATIP (atipt.com)|CareMax Medical Group - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal KDLY|MODV: Rasio utang jangka dawa marang ekuitas|novointegrated.com - Rasio silihan jangka dawa marang modal|SSY: Utang jangka dawa marang modal|IMAC Holdings Inc - Koefisien utang jangka dawa marang modal